This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Health Discovery Corporation And Doctors Optimal Formula To Develop World’s First SVM-Based Retinal Image Analysis For Retinal Disease Assessment And Treatment Protocol

Health Discovery Corporation (OTCBB: HDVY), a molecular diagnostics leader in the use of patent protected advanced mathematical techniques for personalized medicine, has signed a Letter of Intent with anti-aging, health and wellness company, Doctors Optimal Formula LLC, to create Retinalyze, LLC, an equally owned joint venture, to develop the first SVM-based retinal image analysis for retinal disease assessment and treatment protocols. Designed to assist physicians, the first product "Retinalyze Analytics Software" will use state-of-the-art mathematical algorithms and image-based pattern recognition technology to capture and analyze eye diseases such as age-related macular degeneration (AMD), the leading cause of blindness in adults 55 years and older.

“With Health Discovery’s SVM technology having been successfully applied to digital pathology and radiology in various applications, we are excited to develop Retinalize Analytics, with the expertise provided by the Doctors Optimal Formula’s Ophthalmology experts, to be able to address the needs of the potentially billion people throughout the world with life altering retinal diseases such as macular degeneration,” explains Stephen D. Barnhill, M.D., Chairman and CEO of Health Discovery Corporation.

AMD Alliance International reports the worldwide cost of visual impairment due to AMD alone at $343 billion, including $255 billion in direct health care costs. In North America alone, the associated health costs of AMD is near $98 billion. Even more importantly, these costs are set to rise dramatically through 2020 unless effective prevention and treatment strategies are adopted worldwide.

“Retinalyze Analytics will help physicians better "see" retina associated diseases, thereby providing a more accurate diagnostic interpretation of the images analyzed. With more than 400,000 optometrists, ophthalmologists and primary care providers testing and diagnosing such diseases in the U.S. alone, Retinalyze Analytics has the potential to become THE industry-changing standard for retinal testing,” explains Howard Loff, M.D., a leading oculoplastic surgeon and CEO and founder of Doctors Optimal Formula LLC. “We have great confidence that the SVM technology guided by HDC's expertise can successfully assist physicians with improvement in the interpretation of retinal images that are currently part of standard ophthalmologic exams. Beginning at age 40, it is recommended that all adults be screened for eye disease every two years unless there are indications requiring more frequent screening. Additionally, our proprietary technology will store images and assist in the early detection of any changes thereby optimizing a physician's diagnosis allowing early treatment to prevent vision loss, blindness, disability and premature death.”

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,776.91 +93.33 0.53%
S&P 500 2,081.34 +12.58 0.61%
NASDAQ 4,997.4590 +5.5190 0.11%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs